Skip to main content
. 2020 Nov 3;52(10):1875–1882. doi: 10.1017/S0033291720003700

Table 3.

Estimate initial and change in GAD-7 score (previous 2 weeks) according to patient reported Global ratings and time 1 CISR

Global Rating Scale N(*) Feeling better N(*) Feeling same N(*) Feeling worse
Mean 95% CI Mean 95% CI Mean 95% CI
Baseline CIS-R Initial GAD-7
≤11 36 3.05 (2.26 4.01) 78 1.92 (1.51 2.37) 9 5.24 (3.07 7.88)
12–19 25 5.62 (4.14 7.26) 58 6.23 (5.25 7.33) 9 5.24 (3.02 7.82)
20+ 32 9.02 (7.37 10.93) 117 11.12 (10.18 11.98) 36 13.97 (12.38 15.39)
Change per 2 weeks
≤11 −0.81 (−1.18 −0.50) −0.27 (−0.44 −0.11) 0.86 (0.27 1.54)
12–19 −1.50 (−2.04 −1.03) −0.53 (−0.92 −0.11) 0.00 (−0.47 0.50)
20+ −1.56 (−1.96 −1.16) −0.42 (−0.76 −0.08) 0.67 (0.28 1.06)
Change per 2 weeks as a percentage of baseline GAD7 score
≤11 −0.26 (−0.34 −0.19) −0.14 (−0.21 −0.06) 0.17 (0.05 0.30)
12–19 −0.27 (−0.34 −0.20) −0.09 (−0.15 −0.02) 0.00 (−0.09 0.10)
20+ −0.17 (−0.22 −0.13) −0.04 (−0.07 −0.01) 0.05 (0.02 0.08)
(*)

N denotes sample size at baseline for each group. Detailed account of the number of participants contributing to the estimates in each visit is given in Appendix 2 Figure S2.1.